Sisaf Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sisaf Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11217
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSillic-RX, for gene therapy or oral delivery of large unstable peptides and proteins; ProSillic-OTC products, for cosmeceuticals or nutraceuticals. Sisaf’s platform technology uses elemental silicon particle to allow active compounds to penetrate into the deeper layers of the skin and finds application in the treatment of diseases such as skin melanoma, acne, psoriasis, scar, wound healing, cancer, diabetes, and Alzheimers disease, among others. The company provides formulation services; and licenses its technologies to clients in the life science industry. Its products are used in pharmaceutical, cosmetics, biotech, and lab technology sectors. Sisaf is headquartered in Belfast, the UK.

Sisaf Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sisaf Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sisaf Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sisaf Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Sisaf Raises USD4.3 Million in Venture Financing 11
SiSaf Raises USD3.5 Million in Series A Financing 12
SiSaf Raises USD0.6 Million in Venture Financing 13
SiSaf Raises USD0.8 Million in Venture Financing 14
Private Equity 15
SiSaf Plans to Raise Funds in Financing Round 15
Partnerships 16
Croda International and SiSaf Enter into Agreement 16
Acquisition 17
Croda International Acquires Minority Stake in SiSaf 17
Sisaf Ltd – Key Competitors 18
Sisaf Ltd – Key Employees 19
Sisaf Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Sisaf Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sisaf Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sisaf Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Sisaf Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sisaf Raises USD4.3 Million in Venture Financing 11
SiSaf Raises USD3.5 Million in Series A Financing 12
SiSaf Raises USD0.6 Million in Venture Financing 13
SiSaf Raises USD0.8 Million in Venture Financing 14
SiSaf Plans to Raise Funds in Financing Round 15
Croda International and SiSaf Enter into Agreement 16
Croda International Acquires Minority Stake in SiSaf 17
Sisaf Ltd, Key Competitors 18
Sisaf Ltd, Key Employees 19
Sisaf Ltd, Other Locations 20
Sisaf Ltd, Subsidiaries 20

List of Figures
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sisaf Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Sisaf Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Talon Petroleum Ltd (TPD):石油・ガス:M&Aディール及び事業提携情報
    Summary Talon Petroleum Ltd (Talon Petroleum) is an oil and gas company. The company operates in the business of exploration, development, and production of petroleum resources. Its principal project include Mosman Rockingham (MR) Olmos project, which is located in McMullen County, Texas. Talon Petr …
  • The Japan Steel Works Ltd:企業の戦略・SWOT・財務情報
    The Japan Steel Works Ltd - Strategy, SWOT and Corporate Finance Report Summary The Japan Steel Works Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Precision Drilling Corporation (PD):石油・ガス:M&Aディール及び事業提携情報
    Summary Precision Drilling Corp (Precision) is a provider of onshore drilling and production services to exploration and production companies in the oil and natural gas industry. It offers contract drilling, well servicing and other support services to oil and natural gas exploration and production …
  • Mohammad Al-Mojil Group:企業の戦略・SWOT・財務情報
    Mohammad Al-Mojil Group - Strategy, SWOT and Corporate Finance Report Summary Mohammad Al-Mojil Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • La Francaise Des Jeux SA:企業の戦略的SWOT分析
    La Francaise Des Jeux SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Athabasca Oil Corp (ATH):石油・ガス:M&Aディール及び事業提携情報
    Summary Athabasca Oil Corp (Athabasca) is an upstream energy company which focuses on exploration, development and production of bitumen, light oil and liquids-rich natural gas from oil sands and related assets. The company employs multi-stage fracturing and horizontal drilling technology from uncon …
  • Aspen Technology Inc (AZPN):企業の財務・戦略的SWOT分析
    Aspen Technology Inc (AZPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Debiopharm International SA-医療機器分野:企業M&A・提携分析
    Summary Debiopharm International SA (Debiopharm), a subsidiary of Debiopharm Group is a biopharmaceutical company that develops prescription drugs. The company offers a range of licensing and drug development solutions. It evaluates, searches, and in-licenses promising drug candidates for developmen …
  • Labrador Iron Mines Holdings Limited:企業の戦略・SWOT・財務情報
    Labrador Iron Mines Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Labrador Iron Mines Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Nigerian National Petroleum Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Nigerian National Petroleum Corp (NNPC) is a state-owned vertically integrated oil and gas company, which explores for, produces, markets and distributes crude oil, refined petroleum, petrochemicals and associated by-products. It operates through a network of refineries that produce products …
  • Constellation Software Inc (CSU):企業の財務・戦略的SWOT分析
    Constellation Software Inc (CSU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Micromem Technologies Inc (MRM):企業の財務・戦略的SWOT分析
    Summary Micromem Technologies Inc (Micromem) operates as a technology company that develops and markets magnetic sensor products. The company designs and develops sensors specific to industrial requirements. It offers solutions such as nanoparticle detection solutions, structural integrity sensors, …
  • Boralex Inc (BLX):電力:M&Aディール及び事業提携情報
    Summary Boralex Inc (Boralex) is a renewable energy company. It develops, builds, and operates renewable energy power facilities. The company’s asset portfolio includes wind, hydro, thermal, and solar projects. Boralex also has interests in various projects under development stages. Under long-term …
  • Nordstrom, Inc.:企業の戦略・SWOT・財務情報
    Nordstrom, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nordstrom, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Avingtrans Plc (AVG):企業の財務・戦略的SWOT分析
    Avingtrans Plc (AVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • National Bank of Canada:企業の戦略・SWOT・財務情報
    National Bank of Canada - Strategy, SWOT and Corporate Finance Report Summary National Bank of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ironshore, Inc.:企業の戦略・SWOT・財務情報
    Ironshore, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ironshore, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • European Bank for Reconstruction and Development:企業のM&A・事業提携・投資動向
    European Bank for Reconstruction and Development - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's European Bank for Reconstruction and Development Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …
  • Plantronics, Inc. (PLT):企業の財務・戦略的SWOT分析
    Plantronics, Inc. (PLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Epic Pharma LLC-製薬・医療分野:企業M&A・提携分析
    Summary Epic Pharma LLC (Epic Pharma), a subsidiary of Humanwell Healthcare (Group) Co Ltd is a drug company that develops and manufactures generic prescription drugs. The company’s products include citalopram, betaxolol, amlodipine besylate, meperidine hydrochloride, flacoxate hydrochloride, nicard …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆